The CD69 protein (CD69 Molecule) is a C-type lectin receptor family member involved in Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
| CD69 (CD69 Molecule) | |
|---|---|
| Official Symbol | CD69 |
| Gene | CD69 |
| Chromosomal Location | 12p13.31 |
| UniProt ID | Q07108 |
| Molecular Weight | 22-28 kDa (glycosylated) |
| Subcellular Localization | Cell membrane, early endosomes |
| Protein Family | C-type lectin receptor family |
Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This protein plays important roles in cellular signaling pathways relevant to neurodegenerative disease pathogenesis.
CD69 participates in key signaling cascades:
Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. In the central nervous system, this protein:
CD69 is implicated in Alzheimer's disease through:
In Parkinson's disease:
CD69 plays a role in:
CD69 is being investigated as a therapeutic target:
CD69 interacts with:
The study of Cd69 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.